Detalhe da pesquisa
1.
Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis.
J Cell Biochem
; 119(3): 2653-2665, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29058760
2.
Combined immunotherapy with whole tumor lysate-pulsed interleukin-15-activated dendritic cells and cucurbitacin I promotes strong CD8(+) T-cell responses and cures highly aggressive lymphoma.
Cytotherapy
; 17(5): 647-64, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25769790
3.
Screening of Novel Inhibitors Against Leishmania donovani Calcium ion Channel to Fight Leishmaniasis.
Infect Disord Drug Targets
; 17(2): 120-129, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28034363
4.
Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro.
J Leukoc Biol
; 72(2): 312-20, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12149422
5.
Tumor antigen-/cytokine-pulsed dendritic cells in therapy against lymphoma.
Methods Mol Biol
; 1139: 45-56, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24619670
6.
CD47 augments Fas/CD95-mediated apoptosis.
J Biol Chem
; 280(33): 29637-44, 2005 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-15917238
7.
Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer.
Int J Cancer
; 102(5): 499-506, 2002 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12432553
8.
Generation of CD8+ cytotoxic T lymphocytes against breast cancer cells by stimulation with mammaglobin-A-pulsed dendritic cells.
Breast Cancer Res Treat
; 79(1): 133-6, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12779090